NEUROCUPLE™ in TKA Patients to Enhance Pain Management
NCT: NCT06460350 · COMPLETED
Brief Summary
This is a randomized (1:1) placebo-controlled clinical trial to determine the feasibility and effectiveness of 30-day application of NEUROCUPLE™ patch for pain reduction and opioid consumption following TKA. Results will establish NEUROCUPLE™ as an effective non-opioid postoperative pain management device for FDA approval. Importantly, we have a placebo device (device without the captor array layer) that looks exactly like the active device, allowing us to conduct a true placebo randomized study.
Frequently Asked Questions
What is NEUROCUPLE™ in TKA Patients to Enhance Pain Management?
NEUROCUPLE™ in TKA Patients to Enhance Pain Management is a clinical trial registered under NCT06460350. Current status: COMPLETED.
What is the status of NCT06460350?
The current status of NCT06460350 (NEUROCUPLE™ in TKA Patients to Enhance Pain Management) is: COMPLETED.
When did NEUROCUPLE™ in TKA Patients to Enhance Pain Management start?
NEUROCUPLE™ in TKA Patients to Enhance Pain Management started on 2024-09-25.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.